Skip to content

Evaluation of 2%Bromelain Gel With 0.2%CHX Gel as Subgingival LDD Following SRP in Stage II/III and Grade B Periodontitis -A RCT

Evaluation of 2%Bromelain Gel With 0.2%Chlorhexidine Gel as Subgingival Local Drug Delivery Following Scaling and Root Planing in Stage II/III and Grade B Periodontitis -Randomized Control Clinical Trail

Status
Recruiting
Phases
Phase 1
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06505759
Enrollment
36
Registered
2024-07-17
Start date
2024-07-01
Completion date
2025-07-31
Last updated
2025-01-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Periodontal Pocket

Brief summary

The current study is a prospective randomised study Evaluation of 2%Bromelain Gel With 0.2%Chlorhexidine Gel as Subgingival Local Drug Delivery Following Scaling and Root Planing in Stage II/III and Grade B Periodontitis

Detailed description

36 sites with periodontal pocket depth measuring 4-6mm were selected. The sites selected were divided into 1. Group I (Control)- 12 sites with Probing depth of ≥5mm treated with scaling and root planing alone. 2. Group II -12 sites with Probing depth of ≥5mm treated with scaling and root planing followed by placement of bromelain gel. 3. Group III -12 sites with Probing depth of ≥5mm treated with scaling and root planing followed by placement of chlorhexidine gel. periodontal pack was placed and patient was recalled at 1week,4th week and 12th week

Interventions

DRUGBromelain gel

bromelain gel is prepared from bromelain capsules in laboratory

chlorhexidine gel is prepared from mouth wash

PROCEDURESRP

Scaling and root planing was done with ultra sonic and hand scaling

Sponsors

Krishnadevaraya College of Dental Sciences & Hospital
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
30 Years to 50 Years
Healthy volunteers
Yes

Inclusion criteria

* Patient with have chronic periodontitis in the age group between 30-50 years. * Patients having ≥20 teeth. -.Patients with radiographic evidence of bone loss in atleast two teeth. * Patients who are systematically healthy. * Patients with localized pockets with probing depth of ≤ 5mm. * Patients who are cooperative and able to attend the hospital for regular follow-up.

Exclusion criteria

* Patients who have received any surgical or nonsurgical therapy during past 6months * Pregnant or lactating females. * Use of systemic antibiotics in the past 6 months. * Patient who are not willing to give a written informed consent

Design outcomes

Primary

MeasureTime frameDescription
Probing pocket Depth (PPD)3 monthsmeasured using a UNC-15 probe (university of North Carolina-15 periodontal probe- Hu-Friedy, Chicago, IL, USA
Relative attachment level (RAL)3 months(university of North Carolina-15 periodontal probe- Hu-Friedy, Chicago, IL, USA)

Secondary

MeasureTime frameDescription
Plaque Index3 monthsmeasured on the tooth surface using a probe
Gingival index3 monthmeasured on the tooth surface using a probe
Modified Sulcus Bleeding Index3 monthsmeasured on the tooth surface using a probe

Countries

India

Contacts

Primary ContactDR .Prabhuji MLV, MDS
prabhujimlv@gmail.com9448057407
Backup ContactDR.NALLAGATLA VAMSI VENKATAKRISHNA SAI, MDS
vamsi.prince.sai17@gmail.com8499086673

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026